These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer. Földi M; Stickeler E; Bau L; Kretz O; Watermann D; Gitsch G; Kayser G; Zur Hausen A; Coy JF Oncol Rep; 2007 Apr; 17(4):841-5. PubMed ID: 17342325 [TBL] [Abstract][Full Text] [Related]
4. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Coy JF; Dressler D; Wilde J; Schubert P Clin Lab; 2005; 51(5-6):257-73. PubMed ID: 15991799 [TBL] [Abstract][Full Text] [Related]
5. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer. Krockenberger M; Engel JB; Schmidt M; Kohrenhagen N; Häusler SF; Dombrowski Y; Kapp M; Dietl J; Honig A Anticancer Res; 2010 May; 30(5):1653-9. PubMed ID: 20592357 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. Zerilli M; Amato MC; Martorana A; Cabibi D; Coy JF; Cappello F; Pompei G; Russo A; Giordano C; Rodolico V Cancer; 2008 Sep; 113(5):936-44. PubMed ID: 18615628 [TBL] [Abstract][Full Text] [Related]
7. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. Lange CA; Tisch-Rottensteiner J; Böhringer D; Martin G; Schwartzkopff J; Auw-Haedrich C Ophthalmology; 2012 Sep; 119(9):1924-9. PubMed ID: 22658715 [TBL] [Abstract][Full Text] [Related]
8. Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells. Zhang S; Yang JH; Guo CK; Cai PC Cancer Lett; 2007 Aug; 253(1):108-14. PubMed ID: 17321041 [TBL] [Abstract][Full Text] [Related]
9. [Effects of transketolase-like gene TKTL1 on occurrence and metastasis of human nasopharyngeal carcinoma]. Zhang S; Yang JH; Cai PC Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3131-4. PubMed ID: 19159596 [TBL] [Abstract][Full Text] [Related]
10. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression. Kayser G; Sienel W; Kubitz B; Mattern D; Stickeler E; Passlick B; Werner M; Zur Hausen A Pathology; 2011 Dec; 43(7):719-24. PubMed ID: 22027741 [TBL] [Abstract][Full Text] [Related]
11. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Xu X; Zur Hausen A; Coy JF; Löchelt M Int J Cancer; 2009 Mar; 124(6):1330-7. PubMed ID: 19065656 [TBL] [Abstract][Full Text] [Related]
12. Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas. Völker HU; Hagemann C; Coy J; Wittig R; Sommer S; Stojic J; Haubitz I; Vince GH; Kämmerer U; Monoranu CM Am J Clin Pathol; 2008 Jul; 130(1):50-7. PubMed ID: 18550470 [TBL] [Abstract][Full Text] [Related]
13. TKTL1 and p63 are biomarkers for the poor prognosis of gastric cancer patients. Song Y; Liu D; He G Cancer Biomark; 2015; 15(5):591-7. PubMed ID: 26406948 [TBL] [Abstract][Full Text] [Related]
14. Transketolase-like protein 1 confers resistance to serum withdrawal in vitro. Hartmannsberger D; Mack B; Eggert C; Denzel S; Stepp H; Betz CS; Gires O Cancer Lett; 2011 Jan; 300(1):20-9. PubMed ID: 20884117 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer. Bentz S; Cee A; Endlicher E; Wojtal KA; Naami A; Pesch T; Lang S; Schubert P; Fried M; Weber A; Coy JF; Goelder S; Knüchel R; Hausmann M; Rogler G Digestion; 2013; 88(3):182-92. PubMed ID: 24193262 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: a potential therapeutic target in nasopharyngeal carcinoma. Zhang S; Yue JX; Yang JH; Cai PC; Kong WJ Cancer Biol Ther; 2008 Apr; 7(4):517-22. PubMed ID: 18296915 [TBL] [Abstract][Full Text] [Related]
17. Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer. Semilia M; Hennenlotter J; Pavone C; Bischoff T; Kühs U; Gakis G; Bedke J; Stenzl A; Schwentner C; Todenhöfer T World J Urol; 2015 Oct; 33(10):1403-9. PubMed ID: 25572961 [TBL] [Abstract][Full Text] [Related]
18. [Alteration of early growth response 1 expression in gastroenterological cancers and its biological significance]. An J; Guo RF; Zhang L; Geng PL; Lü YY Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1384-9. PubMed ID: 18953875 [TBL] [Abstract][Full Text] [Related]
19. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246 [TBL] [Abstract][Full Text] [Related]
20. Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells. Jayachandran A; Lo PH; Chueh AC; Prithviraj P; Molania R; Davalos-Salas M; Anaka M; Walkiewicz M; Cebon J; Behren A BMC Cancer; 2016 Feb; 16():134. PubMed ID: 26907172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]